Veterinary Medicines

ZOLETIL 100 (50 mg/ml + 50 mg/ml) lyophilisate and solvent for solution for injection for dogs and cats

Authorised
  • Tiletamine hydrochloride
  • Water for injection
  • Zolazepam hydrochloride
Download as PDF

Product identification

Medicine name:
ZOLETIL 100 (50 MG/ML + 50 MG/ML) LYOPHILISATE AND SOLVENT FOR SOLUTION FOR INJECTION FOR DOGS AND CATS
ZOLETIL 100 (50 mg/ml + 50 mg/ml) lyophilisate and solvent for solution for injection for dogs and cats
Active substance:
  • Tiletamine hydrochloride
  • Water for injection
  • Zolazepam hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Tiletamine hydrochloride
    290.86
    milligram(s)
    /
    1.00
    Bottle
  • Water for injection
    5.00
    millilitre(s)
    /
    1.00
    Bottle
  • Zolazepam hydrochloride
    281.88
    milligram(s)
    /
    1.00
    Bottle
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Intravenous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01AX99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • 10 vials of 970 mg lyophilisate and 10 vials of 5 ml solvent
  • 1 vial of 970 mg lyophilisate and 1 vial of 5 ml solvent

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10988/099/002
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0283/002
Concerned member states:
  • Austria
  • Finland
  • Germany
  • Ireland
  • Malta
  • Netherlands
  • Poland
  • Romania
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."